Buse is a professor in the UNC School of Medicine and chief of the division of endocrinology and metabolism and director of the UNC Diabetes Care Center. He also serves on the steering committee for the North Carolina Translational and Clinical Sciences (NC TraCS) Institute -- the academic home of the NIH Clinical and Translational Sciences Awards (CTSA) at UNC -- where Buse is a PI extender in Clinical Research.
He is also an active clinician who treats patients both at UNC Hospitals in Chapel Hill and at the Highgate Specialty Center in Durham, which is one of UNC Health Care’s community practices.
The awards ceremony will take place in New York on March 22. Additional information about the Castle Connolly National Physician of the Year Awards is available at .
A native of Charleston, S.C., Buse received his bachelor's degree in biochemistry from Dartmouth College and his medical and doctoral degrees from Duke University. He completed his internship and residency in internal medicine and his fellowship in endocrinology at the University of Chicago. He has been a member of the UNC faculty since 1994.
Buse was also the American Diabetes Association’s president for medicine and science in 2007-2008. Buse’s involvement with the association goes back to his childhood when he traveled to ADA’s Annual Scientific Sessions with his parents, who are diabetes specialists engaged in research, clinical care, and teaching. Buse is a former associate editor of the ADA journals Clinical Diabetes and Diabetes Care, which provide information on state-of-the-art care and prevention of diabetes to clinicians nationally and internationally. He has chaired several ADA committees and task forces and is an active ADA fundraiser in his community.
His commitment to developing breakthroughs in the prevention and treatment of both type 1 and type 2 diabetes is further evident in his many research initiatives. Buse is the vice chair of the National Institutes of Health’s (NIH’s) largest ever diabetes study, the ACCORD study, which is aimed at determining optimal treatments for diabetes, blood pressure, and cholesterol in type 2 diabetes. He is a co-investigator in the HEALTHY study, another NIH trial aimed to demonstrate that changing school environments can produce weight loss in middle school children.